<DOC>
	<DOC>NCT02347189</DOC>
	<brief_summary>Non-randomized, multi-center, prospective surveillance study to investigate and assess the residual risks, and to confirm the currently established safety and performance of the Melody TPV PB1016.</brief_summary>
	<brief_title>Melody(TM) TPV PB1016 Surveillance Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Defects, Congenital</mesh_term>
	<criteria>Patient eligible to receive Melody TPV PB1016 per current Instructions for Use (IFU) indications at time of study enrollment Patient (or patient's legally authorized representative) is willing to consent to participate in the study and will commit to completion of all followup requirements. Implantation in the aortic, tricuspid, or mitral position Venous anatomy unable to accommodate a 22Fr size introducer sheath Obstruction of the central veins Clinical or biological signs of infection including active endocarditis History of intravenous substance abuse Currently participating in an investigational drug or device study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>